Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04041219
What this trial is testing

Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients

Who this might be right for
ImmunosuppressionStem Cell TransplantBone Marrow Transplant
Mayo Clinic 10
Not applicableEnded earlyNCT00176930
What this trial is testing

Stem Cell Transplant for Hematological Malignancy

Who this might be right for
Leukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more
Masonic Cancer Center, University of Minnesota 330
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)UnknownNCT00005896
What this trial is testing

Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia

Who this might be right for
Fanconi's Anemia
University of Minnesota 6
Testing effectiveness (Phase 2)UnknownNCT03292263
What this trial is testing

ASCT With Nivolumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
St. Petersburg State Pavlov Medical University 30
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Large-scale testing (Phase 3)Ended earlyNCT02145598
What this trial is testing

Treatment Optimization in Patients With Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dr. med. Lars-Olof Muegge 85
Testing effectiveness (Phase 2)Looking for participantsNCT06107738
What this trial is testing

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Barbara Ann Karmanos Cancer Institute 60
Not applicableStudy completedNCT04783038
What this trial is testing

Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Mayo Clinic 30
Early research (Phase 1)Study completedNCT05265767
What this trial is testing

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

Who this might be right for
Hemophilia A
Christian Medical College, Vellore, India 6
Testing effectiveness (Phase 2)WithdrawnNCT04230031
What this trial is testing

Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Study completedNCT05290545
What this trial is testing

Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

Who this might be right for
Hematological MalignanciesHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 314
Testing effectiveness (Phase 2)Study completedNCT01339572
What this trial is testing

Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation

Who this might be right for
Non-Hodgkin's LymphomaMultiple Myeloma
University of Florida 72
Testing effectiveness (Phase 2)Study completedNCT01553357
What this trial is testing

Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia

Who this might be right for
Primary Plasma Cell Leukemia
IRCCS Centro di Riferimento Oncologico della Basilicata 23
Not applicableStudy completedNCT04853277
What this trial is testing

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

Who this might be right for
Stem Cell TransplantCAR T-Cell TransplantCAR T-Cell Therapy+6 more
Dartmouth-Hitchcock Medical Center 31
Not applicableWithdrawnNCT02127905
What this trial is testing

Unrelated HSCT in Patients With Fanconi Anemia

Who this might be right for
Fanconi Anemia
Neena Kapoor, M.D.
Early research (Phase 1)Ended earlyNCT02716805
What this trial is testing

Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Ludwig Institute for Cancer Research 6
Large-scale testing (Phase 3)Study completedNCT00207805
What this trial is testing

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre National de Greffe de Moelle Osseuse 202
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Next Page